Every lot published · search any lot number before you order

Retatrutide and Gastrointestinal Adverse Events

Gastrointestinal adverse events were prominent in the retatrutide obesity program. Studies generally report the type of event and how frequently it was observed in each group.

Retatrutide and Gastrointestinal Adverse Events. Frequency, severity and discontinuation. Study design, Measure, Interpretation. GLP LIFE SCIENCES · RESEARCH BRIEF 42 Frequency, severity and discontinuation Safety and methods Study designMeasureInterpretation
Frequency, severity and discontinuation. Illustration for this research brief.

Frequency, severity and discontinuation

Frequency, intensity and treatment discontinuation are distinct outcomes. An event can be common while a smaller proportion of participants stop treatment because of it.

How to interpret the evidence

Use the same definition and denominator when comparing event rates across trial groups.

This research summary focuses on a defined endpoint or safety observation. Its relevance depends on the study’s population and follow-up.

Sources